Innopharma was recognized for its 20+ years of excellence in pharmaceutical research and its role in translating academic innovation into clinical applications. The jury emphasized the group’s female leadership, noting the importance of gender equity in science.
Certifications and awards
Recognized excellence at the service of drug discovery.
Our commitment to quality and innovation is reflected in the certifications and awards received, both at institutional and individual levels.
As a company, we have been recognized for achieving and maintaining high capacities and standards in drug discovery services, while our professional team has earned prestigious awards for scientific leadership, research excellence, and contributions to the field.
Company and group recognitions
Galicia Spin-Off Award
- GCiencia Xornalismo e divulgación
- GCiencia Xornalismo e divulgación
- 2024
2024
Excelencia Maria de Maeztu
- Agencia Estatal de Investigación (AEI)
- Agencia Estatal de Investigación (AEI)
- 2025-2031
The María de Maeztu Excellence Awards are part of a Spanish national initiative aimed at promoting cutting-edge scientific research. Their mission is to recognize and support research units that demonstrate international leadership, scientific excellence, and the ability to generate high-impact knowledge.
The María de Maeztu Excellence Awards are part of a Spanish national initiative aimed at promoting cutting-edge scientific research. Their mission is to recognize and support research units that demonstrate international leadership, scientific excellence, and the ability to generate high-impact knowledge.
2025-2031
European reference and high capacity infrastructure in early drug discovery member of EU-OPENSCREEN
- European Research Infrastructure Consortium (ERIC)
- European Research Infrastructure Consortium (ERIC)
- Since 2023
EU-OPENSCREEN is a European Research Infrastructure Consortium (ERIC) dedicated to advancing chemical biology and early drug discovery. Its mission is to provide researchers—both in academia and industry—with access to high-throughput screening platforms, medicinal chemistry expertise, and a shared compound collection of over 300 000 molecules.
Since 2023
Nominal recognitions
Mabel Loza
Featured in the book “Nosotras biocientíficas españolas”
- L’Oréal - Unesco For Women in Science
- L’Oréal - Unesco For Women in Science
- 2022
Mabel Loza was included within the international LOréal-Unesco “For Women in Science” program, in the book entitled “Nosotras biocientíficas españolas” a compendium of women researchers in the Life Sciences in Spain.
2022
Mabel Loza
One of the 30 scientists from 30 countries in Europe within the “Portraits of Science-Scientists of Tomorrow” initiative
- European Federation of Pharmaceutical Industries and Associations
- European Federation of Pharmaceutical Industries and Associations
- 2018
Mabel Loza was selected as one of 30 scientists from 30 European countries featured in the “Portraits of Science – Scientists of Tomorrow” initiative. This recognition highlights her outstanding contributions to biomedical research and her leadership in advancing pharmaceutical innovation.
2018
Mabel Loza - Nominee
“Allende” Award for Knowledge Transfer, from National Awards for Knowledge and Technology Transfer (IPfest)
- Fundación para el Desarrollo de la Ciencia y la Tecnología (FUNDECYT) and Fundación Parque Científico y Tecnológico de Extremadura (PCTEx)
- Fundación para el Desarrollo de la Ciencia y la Tecnología (FUNDECYT) and Fundación Parque Científico y Tecnológico de Extremadura (PCTEx)
- 2024
Mabel Loza, was nominated for the prestigious Allende Award for Knowledge Transfer at the IPfest 2024 national event. The nomination recognizes her pioneering efforts in translating pharmacological research into real-world health solutions, and her long-standing commitment to bridging science and society.
2024
Mabel Loza
Alba de Compostela Award
- Concello de Santiago
- Concello de Santiago
- 2024
Mabel Loza, Scientific Director of CiMUS and the Innopharma platform, received this award in recognition of her leadership and the center’s designation as a María de Maeztu Unit of Excellence. This milestone highlights CiMUS’s role in advancing biomedical research in Galicia and Europe.
2024